DK1294379T3 - En hidtil ukendt anvendelse af deferipron - Google Patents

En hidtil ukendt anvendelse af deferipron

Info

Publication number
DK1294379T3
DK1294379T3 DK01949158T DK01949158T DK1294379T3 DK 1294379 T3 DK1294379 T3 DK 1294379T3 DK 01949158 T DK01949158 T DK 01949158T DK 01949158 T DK01949158 T DK 01949158T DK 1294379 T3 DK1294379 T3 DK 1294379T3
Authority
DK
Denmark
Prior art keywords
deferiprone
patient
novel use
cardiac disease
induced cardiac
Prior art date
Application number
DK01949158T
Other languages
English (en)
Inventor
Michael Spino
Antonia Piga
Original Assignee
Apotex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4166629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1294379(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Apotex Inc filed Critical Apotex Inc
Application granted granted Critical
Publication of DK1294379T3 publication Critical patent/DK1294379T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
DK01949158T 2000-06-30 2001-06-28 En hidtil ukendt anvendelse af deferipron DK1294379T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2313270A CA2313270C (en) 2000-06-30 2000-06-30 Use of deferiprone in treating and preventing iron-induced cardiac disease
PCT/CA2001/000956 WO2002002114A1 (en) 2000-06-30 2001-06-28 A new use for deferiprone

Publications (1)

Publication Number Publication Date
DK1294379T3 true DK1294379T3 (da) 2009-06-02

Family

ID=4166629

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01949158T DK1294379T3 (da) 2000-06-30 2001-06-28 En hidtil ukendt anvendelse af deferipron

Country Status (16)

Country Link
US (2) US7049328B2 (da)
EP (1) EP1294379B1 (da)
CN (3) CN1331971A (da)
AT (1) ATE427107T1 (da)
AU (2) AU2001270402B9 (da)
BR (1) BR0112280A (da)
CA (1) CA2313270C (da)
CY (1) CY1109191T1 (da)
DE (1) DE60138189D1 (da)
DK (1) DK1294379T3 (da)
ES (1) ES2324978T3 (da)
HK (2) HK1043316A1 (da)
IL (2) IL153733A0 (da)
PT (1) PT1294379E (da)
WO (1) WO2002002114A1 (da)
ZA (1) ZA200109322B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008010824A (es) * 2006-02-22 2009-06-08 Arnold Munnich Uso de deferiprona y metodos para tratar y/o prevenir ataxia de friedreich que resulta de manejo intracelular inadecuado de hierro.
PE20081596A1 (es) 2007-03-28 2009-02-05 Apotex Technologies Inc Derivados fluorinados de deferiprona
BRPI0822206B8 (pt) 2008-04-25 2021-05-25 Apotex Tech Inc formulação líquida para deferiprona com um sabor agradável.
JP5611339B2 (ja) 2009-07-03 2014-10-22 アポテックス テクノロジーズ インク．Ａｐｏｔｅｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． ３−ヒドロキシピリジン‐４−オンのフッ素化誘導体
US9849146B2 (en) 2009-07-20 2017-12-26 Rutgers, The State University Of New Jersey Inhibition of nonsense mediated mRNA decay by drugs that prevent hypusination of eukaryotic initiation factor 5A
US8603814B2 (en) * 2009-07-20 2013-12-10 Rutgers The State University Of New Jersey Method of inhibiting nonsense-mediated mRNA decay
EP2780012A4 (en) * 2011-11-18 2015-07-29 Apotex Technologies Inc METHODS OF TREATING WITH DEFERPRONE
WO2016029158A2 (en) * 2014-08-21 2016-02-25 Collaborative Medicinal Development Llc Compositions and methods for extending lifespan
KR20230004944A (ko) * 2016-08-05 2023-01-06 아브페로 파마슈티칼스, 인크. 금속-매개 상태를 치료하기 위한 투여 요법
CN106983746A (zh) * 2017-03-23 2017-07-28 武汉联合药业有限责任公司 一种药物组合物及其用途
WO2019082128A1 (en) * 2017-10-25 2019-05-02 Apotex Inc. DELAYED-RELEASE RELEASE TABLETS AND METHODS OF USE
CN114217071B (zh) * 2021-12-01 2023-11-14 柏荣诊断产品（上海）有限公司 一种高特异性透散射一体法铁蛋白胶乳比浊检测试剂盒
WO2023198640A1 (en) 2022-04-11 2023-10-19 Chiesi Farmaceutici S.P.A. Modified release pharmaceutical formulations comprising deferiprone
CN115429881A (zh) * 2022-09-02 2022-12-06 中国医学科学院基础医学研究所 铁螯合剂治疗β-连环蛋白活化突变的肿瘤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2118176B (en) * 1982-03-24 1985-12-04 Nat Res Dev Pharmaceutical compositions
US5922761A (en) * 1996-09-06 1999-07-13 Medinox, Inc. Methods for in vivo reduction of iron levels and compositions useful therefor

Also Published As

Publication number Publication date
CN101380322B (zh) 2015-06-24
CA2313270A1 (en) 2001-12-30
HK1043316A1 (zh) 2002-09-13
US20060122273A1 (en) 2006-06-08
ZA200109322B (en) 2002-10-21
BR0112280A (pt) 2003-05-13
IL153733A0 (en) 2003-07-06
DE60138189D1 (de) 2009-05-14
AU7040201A (en) 2002-01-14
US7049328B2 (en) 2006-05-23
CN101933924A (zh) 2011-01-05
CN1331971A (zh) 2002-01-23
US20030158234A1 (en) 2003-08-21
HK1130422A1 (en) 2009-12-31
AU2001270402B9 (en) 2006-03-02
WO2002002114A1 (en) 2002-01-10
ES2324978T3 (es) 2009-08-21
CA2313270C (en) 2011-09-13
PT1294379E (pt) 2009-05-04
CY1109191T1 (el) 2014-07-02
CN101380322A (zh) 2009-03-11
EP1294379B1 (en) 2009-04-01
ATE427107T1 (de) 2009-04-15
AU2001270402B2 (en) 2006-02-02
EP1294379A1 (en) 2003-03-26
IL153733A (en) 2010-04-29

Similar Documents

Publication Publication Date Title
CY1109191T1 (el) Μια νεα χρηση της δεφεριπρονης
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
GB0225474D0 (en) Therapeutic agents
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
GB0225475D0 (en) Therapeutic agents
SE9702860D0 (sv) New use
SE9900961D0 (sv) Novel compounds
EP1251126A3 (en) Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
MY119375A (en) Treatment of tinnitus using neuroprotective agents
EE200200107A (et) Kiire algtoimega selektiivse serotoniini tagasihaaramise inhibiitori kasutamine ravimi valmistamiseks, mis on ette nähtud seksuaalse funktsioonihäireravimiseks
GB0130677D0 (en) Medicaments and novel compounds
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
SE0004101D0 (sv) New use
SE9902597D0 (sv) New use
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
NO20032006D0 (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
EE200200549A (et) Jagatud doosi teraapia veresooni kahjustava aktiivsusega
WO2007117272A3 (en) Methods for treatment of hemorrhagic shock and related disorders
EP1270000A3 (en) Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
PT1183046E (pt) Derivado de aminotetralina para a terapia de doencas cardiovasculares